Project Number GC-2012941 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Prevention of cognitive decline in older adults with low DHA/EPA index in red blood cells (Acronym : MAPT 2) Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator Vellas, Bruno Principal Investigator First Name Bruno Principal Investigator Last Name Vellas Awardee Organization Toulouse Centre of Excellence in Neurodegeneration, University Hospital Toulouse Contact PI Country France Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $300,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
